1. Home
  2. GLMD vs DUO Comparison

GLMD vs DUO Comparison

Compare GLMD & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • DUO
  • Stock Information
  • Founded
  • GLMD 2000
  • DUO 2011
  • Country
  • GLMD Israel
  • DUO China
  • Employees
  • GLMD N/A
  • DUO N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • GLMD Health Care
  • DUO Finance
  • Exchange
  • GLMD Nasdaq
  • DUO Nasdaq
  • Market Cap
  • GLMD 7.5M
  • DUO 6.1M
  • IPO Year
  • GLMD 2014
  • DUO 2019
  • Fundamental
  • Price
  • GLMD $1.51
  • DUO $3.38
  • Analyst Decision
  • GLMD Hold
  • DUO
  • Analyst Count
  • GLMD 1
  • DUO 0
  • Target Price
  • GLMD N/A
  • DUO N/A
  • AVG Volume (30 Days)
  • GLMD 224.4K
  • DUO 6.1M
  • Earning Date
  • GLMD 08-28-2025
  • DUO 08-29-2025
  • Dividend Yield
  • GLMD N/A
  • DUO N/A
  • EPS Growth
  • GLMD N/A
  • DUO N/A
  • EPS
  • GLMD N/A
  • DUO N/A
  • Revenue
  • GLMD N/A
  • DUO $56,189,313.00
  • Revenue This Year
  • GLMD N/A
  • DUO N/A
  • Revenue Next Year
  • GLMD N/A
  • DUO N/A
  • P/E Ratio
  • GLMD N/A
  • DUO N/A
  • Revenue Growth
  • GLMD N/A
  • DUO 48.30
  • 52 Week Low
  • GLMD $1.15
  • DUO $1.24
  • 52 Week High
  • GLMD $23.80
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 53.20
  • DUO 58.64
  • Support Level
  • GLMD $1.33
  • DUO $3.15
  • Resistance Level
  • GLMD $1.63
  • DUO $5.34
  • Average True Range (ATR)
  • GLMD 0.11
  • DUO 0.80
  • MACD
  • GLMD 0.03
  • DUO 0.17
  • Stochastic Oscillator
  • GLMD 69.23
  • DUO 50.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: